SEC Form 3/A · accession 0001140361-16-089293
CYTRX CORP · CYTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owner
Earl W Brien
Director
Period of report
Dec 2, 2016
Accepted (ET)
Dec 9, 2016 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000799698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| CytRx Common StockF1 | holding | — | — | — | 61,484 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On the Form 3 first filed on December 6, 2016, it was reported that Dr. Brien beneficially owns 60,000 shares of CytRx common stock.